133 related articles for article (PubMed ID: 2810123)
1. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD
J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123
[TBL] [Abstract][Full Text] [Related]
2. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Verhoef JC; de Boer AG; Breimer DD
Pharm Res; 1990 Feb; 7(2):180-3. PubMed ID: 2106676
[TBL] [Abstract][Full Text] [Related]
3. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
Baldwin PA; Klingbeil CK; Grimm CJ; Longenecker JP
Pharm Res; 1990 May; 7(5):547-52. PubMed ID: 2367323
[TBL] [Abstract][Full Text] [Related]
4. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo.
van Hoogdalem EJ; Vermeij-Kerrs C; de Boer AG; Breimer DD
J Pharm Sci; 1990 Oct; 79(10):866-70. PubMed ID: 2280353
[TBL] [Abstract][Full Text] [Related]
5. 3-Amino-1-hydroxypropylidene-1,1-diphosphonate (APD): a novel enhancer of rectal cefoxitin absorption in rats.
van Hoogdalem EJ; Wackwitz AT; de Boer AG; Breimer DD
J Pharm Pharmacol; 1989 May; 41(5):339-41. PubMed ID: 2569522
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.
Kissel T; Drewe J; Bantle S; Rummelt A; Beglinger C
Pharm Res; 1992 Jan; 9(1):52-7. PubMed ID: 1589410
[TBL] [Abstract][Full Text] [Related]
7. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD
J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101
[TBL] [Abstract][Full Text] [Related]
8. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
Deurloo MJ; Hermens WA; Romeyn SG; Verhoef JC; Merkus FW
Pharm Res; 1989 Oct; 6(10):853-6. PubMed ID: 2692018
[TBL] [Abstract][Full Text] [Related]
9. Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.
Van Hoogdalem EJ; Wackwitz AT; De Boer AG; Cohen AF; Breimer DD
Br J Clin Pharmacol; 1989 Jan; 27(1):75-81. PubMed ID: 2706190
[TBL] [Abstract][Full Text] [Related]
10. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
Lee WA; Narog BA; Patapoff TW; Wang YJ
J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529
[TBL] [Abstract][Full Text] [Related]
11. The use of phenothiazines to enhance the rectal absorption of water-soluble compounds.
Fix JA; Leppert PS; Porter PA; Alexander J
J Pharm Pharmacol; 1984 Apr; 36(4):286-8. PubMed ID: 6144788
[TBL] [Abstract][Full Text] [Related]
12. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.
Longenecker JP; Moses AC; Flier JS; Silver RD; Carey MC; Dubovi EJ
J Pharm Sci; 1987 May; 76(5):351-5. PubMed ID: 3309255
[TBL] [Abstract][Full Text] [Related]
13. Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in conscious rats: concentration-effect relationship.
van Hoogdalem EJ; Hardens MA; de Boer AG; Breimer DD
Pharm Res; 1988 Jul; 5(7):453-6. PubMed ID: 3247317
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique.
Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
Biol Pharm Bull; 1999 Oct; 22(10):1089-93. PubMed ID: 10549861
[TBL] [Abstract][Full Text] [Related]
15. Absorption enhancement of rectally infused cefoxitin by medium chain monoglycerides in conscious rats.
Watanabe Y; van Hoogdalem EJ; de Boer AG; Breimer DD
J Pharm Sci; 1988 Oct; 77(10):847-9. PubMed ID: 3236226
[TBL] [Abstract][Full Text] [Related]
16. Absorption-promoting adjuvants: animal studies on their effects on rectal drug absorption.
Caldwell L; Nishihata T; Fix J; Selk S; Cargill R; Gardner CR; Higuchi T
Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):503-7. PubMed ID: 6392793
[No Abstract] [Full Text] [Related]
17. Possible mechanism behind the adjuvant action of phosphate derivatives on rectal absorption of cefoxitin in rats and dogs.
Nishihata T; Lee CS; Nghiem BT; Higuchi T
J Pharm Sci; 1984 Nov; 73(11):1523-5. PubMed ID: 6520749
[TBL] [Abstract][Full Text] [Related]
18. Absorption enhancers as tools to determine the route of nasal absorption of peptides.
Donnelly A; Kellaway IW; Taylor G; Gibson M
J Drug Target; 1998; 5(2):121-7. PubMed ID: 9588868
[TBL] [Abstract][Full Text] [Related]
19. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro.
Hermens WA; Hooymans PM; Verhoef JC; Merkus FW
Pharm Res; 1990 Feb; 7(2):144-6. PubMed ID: 2408030
[TBL] [Abstract][Full Text] [Related]
20. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.
Lee WA; Ennis RD; Longenecker JP; Bengtsson P
Pharm Res; 1994 May; 11(5):747-50. PubMed ID: 8058647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
